Dr. Patrick Thompson, M.D.
Claim this profileUniversity of North Carolina
Studies Neuroblastoma
Studies Soft Tissue Sarcoma
9 reported clinical trials
24 drugs studied
Area of expertise
1Neuroblastoma
ALK positive
2Soft Tissue Sarcoma
Stage IV
PAX/FOXO1 fusion positive
Affiliated Hospitals
Clinical Trials Patrick Thompson, M.D. is currently running
Oral Irinotecan + Temozolomide
for Pediatric Solid Cancers
This trial is testing a new flavored oral medicine called Orotecan® combined with temozolomide to treat children and young adults with recurring solid tumors. The treatment works by damaging the DNA of cancer cells to stop their growth. Temozolomide has been used in various trials for treating different types of tumors, including gliomas and medulloblastomas.
Recruiting1 award Phase 16 criteria
Biology Study
for Neuroblastoma
Medical scientists want to find better ways to treat neuroblastoma and to find ways to prevent the tumor from growing back. To do this, they need more information about the characteristics of neuroblastoma cells. Therefore, they want to study samples of neuroblastoma tissues and neuroblastoma and normal cells in the blood and bone marrow that may be related to the growth of neuroblastoma cells. Doctors and other medical scientists also want to find better ways to detect and measure neuroblastoma to improve the ability to follow the response of tumor cells to therapy.
Recruiting1 award N/A4 criteria
More about Patrick Thompson, M.D.
Clinical Trial Related4 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Patrick Thompson, M.D. has experience with
- Cyclophosphamide
- Dinutuximab
- Azacitidine
- Nivolumab
- Post Treatment Surgery
- Temozolomide
Breakdown of trials Patrick Thompson, M.D. has run
Neuroblastoma
Soft Tissue Sarcoma
Bone Cancer
Rhabdomyosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick Thompson, M.D. specialize in?
Patrick Thompson, M.D. focuses on Neuroblastoma and Soft Tissue Sarcoma. In particular, much of their work with Neuroblastoma has involved ALK positive patients, or patients who are undergoing treatment.
Is Patrick Thompson, M.D. currently recruiting for clinical trials?
Yes, Patrick Thompson, M.D. is currently recruiting for 2 clinical trials in Chapel Hill North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Patrick Thompson, M.D. has studied deeply?
Yes, Patrick Thompson, M.D. has studied treatments such as Cyclophosphamide, Dinutuximab, Azacitidine.
What is the best way to schedule an appointment with Patrick Thompson, M.D.?
Apply for one of the trials that Patrick Thompson, M.D. is conducting.
What is the office address of Patrick Thompson, M.D.?
The office of Patrick Thompson, M.D. is located at: University of North Carolina, Chapel Hill, North Carolina 27599 United States. This is the address for their practice at the University of North Carolina.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.